Seres Therapeutics | 4:持股变动声明-高管 von Moltke Lisa
Seres Therapeutics | 4:持股变动声明-高管 Shaff Eric D.
Seres Therapeutics | 4:持股变动声明-高管 Young Teresa L.
Seres Therapeutics | 4:持股变动声明-高管 Henn Matthew R.
Seres Therapeutics | 4:持股变动声明-高管 Ege David S.
Seres Therapeutics | 4:持股变动声明-高管 DesRosier Thomas
Seres Therapeutics | 4:持股变动声明-董事 Dere Willard H
Seres Therapeutics | 4:持股变动声明-董事 Fraser Claire
Seres Therapeutics | 4:持股变动声明-董事 Biondi Paul
Seres Therapeutics | 4:持股变动声明-董事 Kender Richard N
Seres Therapeutics | 4:持股变动声明-董事 Graves Kurt
Seres Therapeutics | 4:持股变动声明-董事 Ausiello Dennis A
Seres Therapeutics | 4:持股变动声明-董事 Berenson Stephen
Seres Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.5%)
Seres Therapeutics | 4:持股变动声明-高管 Thorell Marella
Seres Therapeutics | 3:首次持股声明-高管 Thorell Marella
Seres Therapeutics | 4:持股变动声明-高管 DesRosier Thomas
Seres Therapeutics | 4:持股变动声明-高管 Shaff Eric D.
Seres Therapeutics | 4:持股变动声明-高管 Henn Matthew R.
Seres Therapeutics | 4:持股变动声明-高管 Young Teresa L.
暂无数据